Celldom offers a cutting-edge live single-cell biology platform designed to analyze cellular morphology, phenotypes, activity, and molecular profiles in real-time with high throughput capabilities. This platform addresses the limitations of traditional bulk analysis and flow cytometry by providing comprehensive molecular and functional readouts from individual cells over extended periods. Key features include the detection of secreted proteins, characterization of cellular migration, quantification of gene expression, and measurement of cell surface protein levels. The system allows for direct observation of dynamic cell behavior without the need for strict isolation, enabling researchers to study the effects of external influences, such as drug applications or cell interactions, in a controlled environment.

The CloneXplorer platform, a next-generation live single-cell assay system, enhances the capabilities of the Celldom platform by integrating functional imaging and molecular readouts with cell retrieval features. It supports high-resolution testing for CAR T-cell potency, monoclonal antibody discovery, and precision medicine applications through continuous observation of over 100,000 cells in a standard 96-well format. The platform employs AI-based cell detection and tracking, facilitating real-time morphological and functional measurements. With its microfluidics-free design, the CloneXplorer allows for efficient processing and analysis of rare cells, making it a valuable tool for drug candidate identification and cell line development.

United States

Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company's cloneXplorer and proprietary nanowell plates uniquely integrates both phenotypic and genomic data at massive scale (up to 100,000s of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology. Learn more at www.celldom.com and follow the company's growth @celldominc on Twitter.

Celldom

Company Details